The incidence and prognosis of myocardial infarct extension were studied prospectively among patients presenting without symptomatic heart failure (Killip class I or II). Infarct extension was defined as a new clinical event (recurrent pain, arrhythmias or worsening hemodynamic status) that occurred at least 24 hours after a documented myocardial infarction and accompanied by at least two of the following: 1) new 
THE INCIDENCE OF EXTENSION of an acute myocardial infarction (MI) varies widely, depending upon the population of patients studied, the method of detection and the criteria for diagnosis. In 1974, Reid et al. 1 reported an 86% incidence of infarct extension in 19 patients with anterior infarction using reelevation of the electrocardiographic ST segment during daily ST-segment mapping as their criterion. Madias et al.2 used clinical criteria, including chest pain, ventricular arrhythmias and elevation of creatine kinase (CK), as well as precordial ST-segment mapping to identify infarct extensions in 48% of 25 patients with anterior infarcts and 50% of 10 patients with inferior infarcts. Kronenberg et al.3 reported infarct extension associated with ST elevation in 33% of 27 patients, six of whom died. Mathey et al. 4 found that abnormal CK release curves suggesting infarct extension were present in 62% of 40 patients. In a postmortem study, Hutchins and Bulkley5 found histologic evidence of recent foci of necrosis around an infarct in 17% of 76 hearts.
We studied the incidence and prognosis of clinically diagnosed MI extensions in a large series of patients. Several authors have suggested that measures designed to reduce myocardial ischemia should favorably alter the incidence of infarct extension and subsequent morbidity. Because efforts to limit infarct size are most appropriate in patients without preceding pump failure, we considered only patients who presented without symptomatic heart failure. Survival rates after hospitalization were calculated by the life-table method and compared at 1 year by chi-square analysis. Because some patients were admitted more than once, posthospital survival rates were calculated from the first admission for a documented MI.
vival rates of 79% and 62%, respectively (combined survival 76%). The I-year survival for patients without evidence of infarct extension was 91% (p < 0.05). The I-year survival for patients with and without infarct extension who survived hospitalization is shown in figure 1. Extension of MI occurred an average of 3.4 days after admission to the hospital (range 30 hours to I I days) ( fig. 2 ). Consistent with a previous report from this institution,6 all patients with an extension occurring after the fifth day had some other serious complication during the first 4 days of care. Congestive heart failure, hypertension and diabetes mellitus were more common in patients with subsequent infarct extension (table 1) . There were no differences in the incidence of early hospital complications among patients with or without infarct extension that would predict the occurrence of an infarct extension (table 2).
Discussion
The incidence of definite or suspected extension of acute MI in this large series of patients without complications was only 13%. Another 12 patients developed cardiogenic shock late in their hospital course without meeting criteria for infarct extension. It could be argued that these patients also had extensions that were not clinically evident. If included, they would raise the incidence of infarct extension to 15%
Results
Definite extensions occurred in 9.4% (43 of 458) of patients admitted from an outpatient facility for acute MI without preceding pump failure. Suspected extensions occurred in an additional 3.3% (15 of 458). Inhospital mortality was 33% (14 of 43) for patients with definite extension and 47% (seven of 15) for patients with suspected extension of MI. The combined hospital mortality was 36% (21 of 58). In contrast, the hospital mortality for patients without infarct extension was significantly lower (p < 0.001) at 9% (36 of 400). The median time from onset of symptoms to hospitalization was 5 hours for the entire population. Seventy-eight percent of patients had the onset of symptoms within 24 hours of hospitalization and 93% were hospitalized within 48 hours.
All in-hospital deaths in patients with infarct extensions, definite or suspected, were due to cardiac causes, i.e., pump failure or cardiac arrest. Of those surviving to leave the hospital, 19% (seven of 37) had moderate pump failure (Killip class III) after the infarct extension.
In patients without infarct extension, 50% of the inhospital deaths (18 of 36) occurred as a result of a cardiac arrest. The remaining deaths were due to cardiogenic shock in 19% (seven of 36) and noncardiac causes in 31% (11 of 36 Mobitz II atrioventricular block 0 0 *Early hospitalization is defined as day 1 or day 2 after admission. Recurrent angina is compared only on day 2, because most patients had pain accompanying the initial infarct.
sion must be initiated upon admission and continued during the early hospital phase.
In an autopsy study, Hutchins and Bulkey5 examined the hearts from patients with clinically diagnosed and histologically proved MIs. Of the 76 hearts examined, only 13 (17%) had recent foci of necrosis around an infarct. Though this study probably included seriously ill patients, infarct extensions were clinically diagnosed in only 14 patients (18%), and 11 were later confirmed histologically. These figures compare favorably with the incidence of infarct extension reported here.
Other authors have reported significantly higher incidences of infarct extension in small series of selected patients. While these studies sometimes included more seriously ill patients, the higher incidences may have been due to the use of less specific criteria for extension, i. The present study shows that clinically defined infarct extensions are associated with a poor hospital and 1-year survival. An incidence of infarct extension of less than 15% is an important factor in designing clinical trials aimed at limiting infarct size where extension is the end point. Large numbers of patients will be needed to show therapeutic benefit and decreased morbidity. Since most infarct extensions occur within the first few days of hospitalization, therapeutic interventions must be initiated in all patients soon after admission.
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